Also known as Graves' Disease, Basedow Disease, and Exophthalmic Goiter
Graves' disease is an autoimmune disease. It most commonly affects the thyroid, frequently causing it to enlarge to twice its size or more (goiter), become overactive, with related hyperthyroid symptoms such as increased heartbeat, muscle weakness, disturbed sleep, and irritability. It can also affect the eyes, causing bulging eyes (exophthalmos). It affects other systems of the body, including the skin, heart, circulation and nervous system.
Source: WikipediaWithin all the people who go to their doctor with graves disease, 27% report having fatigue, 27% report having dizziness, and 21% report having palpitations.
Patients with graves disease often receive hematologic tests, complete blood count, glucose measurement, lipid panel, electrocardiogram, hemoglobin a1c measurement, ultrasonography and other diagnostic procedures (interview; evaluation; consultation) .
The most commonly prescribed drugs for patients with graves disease include thyroxine (synthroid), methimazole, propylthiouracil, propranolol, thyroid (usp) (armour thyroid), pramlintide (symlin), lamivudine, ursodiol (urso), iloprost, bee pollen, sodium tetradecyl sulfate (sotradecol), amiloride / hydrochlorothiazide and bosentan (tracleer) .
Thyroxine (Synthroid) | $8 (28 days) | |
Methimazole | $14 (28 days) | |
Propylthiouracil | $10 (28 days) | |
Propranolol | $18 (28 days) | |
Thyroid (Usp) (Armour Thyroid) | $7 (28 days) | |
Pramlintide (Symlin) | $472 (28 days) | |
Lamivudine | $292 (28 days) | |
Ursodiol (Urso) | ||
Iloprost | ||
Bee Pollen | ||
Sodium Tetradecyl Sulfate (Sotradecol) | ||
Bosentan (Tracleer) | $5485 (28 days) |
Groups of people at highest risk for graves disease include race/ethnicity = other. On the other hand, age 1-4 years and age < 1 years almost never get graves disease.
< 1 years | 0.0x | |
1-4 years | 0.0x | |
5-14 years | 0.2x | |
15-29 years | 0.7x | |
30-44 years | 1.2x | |
45-59 years | 1.5x | |
60-74 years | 1.3x | |
75+ years | 1.3x |
Male | 0.5x | |
Female | 1.4x |
Black | 1.0x | |
Hispanic | 1.4x | |
White | 0.8x | |
Other | 1.8x |